DVAX
Dynavax Technologies Corporation
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$15.50
+0.00%Margins
Gross margin
83.2%
EBITDA margin
-7.8%
EBIT margin
3.2%
Net margin
-13.1%
FCF margin
24.4%
-8.1%
Return on equity
-4.6%
Return on assets
1.3%
Return on invested capital
0.35x
Asset turnover
$90.6M
Cash from operations
$5.52
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2025